# Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users

> **NCT05854667** · PHASE2 · RECRUITING · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 440 (estimated)

## Conditions studied

- Methamphetamine Abuse
- Methamphetamine-dependence
- Addiction, Substance
- Addiction

## Interventions

- **DRUG:** Treatment as Usual plus Placebo
- **DRUG:** Treatment as Usual plus Placebo plus Contingency Management
- **DRUG:** Treatment as Usual plus lisdexamfetamine (LDX-01)
- **DRUG:** Treatment as Usual plus lisdexamfetamine (LDX-01) plus Contingency Management

## Key facts

- **NCT ID:** NCT05854667
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-05
- **Primary completion:** 2027-12
- **Final completion:** 2028-04
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05854667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05854667, "Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05854667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*